John David Finley - 06 Oct 2026 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
07 Oct 2026, 21:35:01 UTC
Prior SEC filing
21 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ryker Willie, Attorney-in-Fact for John David Finley

Key filing fact

John David Finley filed Form 4 for PALISADE BIO, INC. (PALI) on 07 Oct 2026.

Key facts

  • This page summarizes John David Finley's Form 4 filing for PALISADE BIO, INC. (PALI).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 07 Oct 2026, 21:35.

Change

  • Previous filing in this sequence was filed on 21 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001851034 Primary reporting owner

Finley John David

Relationship
CEO CFO, Director
Address
C/O PALISADE BIO, INC., 4600 SOUTH SYRACUSE STREET, SUITE 900, DENVER
Signature
/s/ Ryker Willie, Attorney-in-Fact for John David Finley
Signature date
07 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PALI transaction

Common Stock

Options Exercise

Transaction value
Shares
+3,227,384
Change %
+2496%
Price
Shares after
3,356,672
Date
06 Oct 2026
Ownership
Direct
Footnotes
F1
PALI transaction

Common Stock

Tax liability

Transaction value
Shares
-1,411,982
Change %
-42%
Price
$1.49*
Shares after
1,944,690
Date
06 Oct 2026
Ownership
Direct
Footnotes
F2
PALI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
88,451
Date
06 Oct 2026
Ownership
By FCW Investments, LLC
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PALI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-3,059,800
Change %
-33%
Price
$0.000000*
Shares after
6,119,600
Date
06 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,059,800
Exercise price
Footnotes
F4, F5
PALI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-167,584
Change %
-10%
Price
$0.000000*
Shares after
1,508,249
Date
06 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
167,584
Exercise price
Footnotes
F4, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs").

Footnote F2

Represents the number of shares of common stock the Issuer has withheld to satisfy the Reporting Person's income tax withholding and remittance obligations as part of the settlement of vested RSUs. Accordingly, no shares of common stock will be sold in the public market to satisfy such income tax withholding and remittance obligations associated with the settlement of these vested RSUs.

Footnote F3

The Reporting Person is the managing member of FCW Investments, LLC and has the sole investment and voting power over the securities held by this entity.

Footnote F4

Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Footnote F5

The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Footnote F6

The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following ten quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .